Edition:
United Kingdom

Vericel Corp (VCEL.OQ)

VCEL.OQ on NASDAQ Stock Exchange Capital Market

6.55USD
17 Jan 2018
Change (% chg)

$0.30 (+4.80%)
Prev Close
$6.25
Open
$6.35
Day's High
$6.75
Day's Low
$6.20
Volume
89,772
Avg. Vol
104,355
52-wk High
$6.75
52-wk Low
$2.25

Select another date:

Tue, Jan 2 2018

BRIEF-Vericel Initiates Collaboration with Innovative Cellular Therapeutics   

* VERICEL CORP - ‍INITIATION OF LICENSE AGREEMENT WITH INNOVATIVE CELLULAR THERAPEUTICS FOLLOWING RECEIPT OF $5.1 MILLION UPFRONT,WARRANT PAYMENT FROM ICT​

BRIEF-Vericel Enters Into Expanded $25 Million Debt Facilities With Silicon Valley Bank And Midcap Financial

* VERICEL ENTERS INTO EXPANDED $25 MILLION DEBT FACILITIES WITH SILICON VALLEY BANK AND MIDCAP FINANCIAL TO SUPPORT ACCELERATING MACI UPTAKE AND INCREASED EPICEL USAGE

BRIEF-Vericel reports Q3 loss per share $0.16

* Q3 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S

BRIEF-‍Archon Capital Management reports a 7.56 pct passive stake in Vericel

* Archon Capital Management LLC reports a 7.56 pct passive stake in Vericel Corp of August 23 - SEC filing ​ Source text: (http://bit.ly/2vxJQCK) Further company coverage:

BRIEF-Shanghai Pharmaceuticals Holding to bid for US firm Arbor

* Says it plans to bid for stake in U.S. specialty drug maker Arbor, clarifies media report

BRIEF-Shanghai Fosun Pharmaceutical's unit to bid for US firm Arbor

Aug 14 Shanghai Fosun Pharmaceutical Group Co Ltd

BRIEF-Vericel Q2 loss per share $0.07

* Q2 earnings per share view $-0.20 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Select another date: